Back to search
FDAFDA · Food and drugs·Recall number D-1081-2017

Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100 vials per case. Hospira, Inc., Lake Forest, IL 60045 USA, NDC: 0409-2634-50

Published August 16, 2017 · Recall initiated: July 26, 2017

Summary

FDA records drug Class II recall D-1081-2017, published August 16, 2017 and initiated July 26, 2017. Recalling firm: HOSPIRA INC, LAKE FOREST; Status: Terminated; Reported quantity: 9,009 vials; Lot: Lot #: 56260DD, Exp. 01AUG2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Silicone oil

What to do

Voluntary: Firm initiated · Telephone

Get an email if HYDROMORPHONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HYDROMORPHONE HYDROCHLORIDE
Manufacturer
HOSPIRA INC, LAKE FOREST
Distributor
Nationwide in the USA
Lot
Lot #: 56260DD, Exp. 01AUG2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100 vials per case. Hospira, Inc., Lake Forest, IL 60045 USA, NDC: 0409-2634-50 recalled?

Yes. FDA published recall D-1081-2017 on August 16, 2017. Reported hazard: Presence of Particulate Matter: Silicone oil

What should I do if I have this product?

Voluntary: Firm initiated · Telephone

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HYDROMORPHONE HYDROCHLORIDE.